This proposed Surgical Oncology Research Training Program is designed for high quality interdisciplinary research training for postgraduate M.D.s in surgical training programs. The two years of interdisciplinary basic science research training prepares the trainees for academic research and teaching positions in surgical oncology. Widely advertised, the program will draw highly qualified trainees. Temple University is a leader in the inclusion of women and minorities in its programs, and has the reputation and experience to recruit successfully from these groups. Research training is accomplished through four categories of experience: (1) required core curriculum, (2) preceptor directed laboratory training in one of five areas of oncology research, (3) laboratory and clinical research structured interactive seminars, and (4) attendance at scientific meetings and appropriate symposia. All participating faculty preceptors have active, funded laboratories and a broad base of experience in basic oncology research. The Surgical Oncology Training Executive Committee consisting of Drs. Reddy, Walsh, Moran, Dempsey, Rao, and the External Advisory Committee Drs. Bland, Copeland, Leffall, Niederhuber, Daly, Dempsey, Walsh, and Rao, provides administrative guidance to the Program Director, evaluates program progress and trainee applications, and suggests direction for future programmatic efforts. The Surgical Oncology Research Advisory Committees consist of members from all of the training areas and currently active preceptors. These committees continuously review the trainees' research progress. The primary research training facilities will be Temple University School of Medicine and the affiliated Fox Chase Cancer Research Center. The training faculty derives from the departments of Surgery, Biochemistry, Pathology, and Microbiology and Immunology at TUSM. Additional preceptors are included from Fox Chase. The majority of the faculty are members of the Fels Institute for Cancer Research and Molecular Biology at TUSM, a research-concentrated component of the School of Medicine. Research and clinical facilities of the Fels Institute, The School of Medicine, Temple University Hospital, The Fox Chase Temple Cancer Center, and Temple University Children's Hospital, are all available to trainees. The Fels Institute maintains the research resources necessary to conduct quality research in a scientifically sound and cost effective manner. The close relationships between the Fels Institute for Cancer Research, the Department of Surgery and the Fox-Chase Cancer Center will offer an outstanding opportunity to increase the number of young surgical investigators committed to excellence in academic surgical oncology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA103652-02
Application #
6917216
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gorelic, Lester S
Project Start
2004-07-02
Project End
2009-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
2
Fiscal Year
2005
Total Cost
$241,474
Indirect Cost
Name
Temple University
Department
Surgery
Type
Schools of Medicine
DUNS #
057123192
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Leclerc, Daniel; Lévesque, Nancy; Cao, Yuanhang et al. (2013) Genes with aberrant expression in murine preneoplastic intestine show epigenetic and expression changes in normal mucosa of colon cancer patients. Cancer Prev Res (Phila) 6:1171-81
Silviera, Matthew L; Smith, Brian P; Powell, Jasmine et al. (2012) Epigenetic differences in normal colon mucosa of cancer patients suggest altered dietary metabolic pathways. Cancer Prev Res (Phila) 5:374-84
Rico, Mario C; Rough, James J; Manns, Joanne M et al. (2012) Assembly of the prothrombinase complex on the surface of human foreskin fibroblasts: Implications for connective tissue growth factor. Thromb Res 129:801-6
Shaw, Christiana M; Stanczyk, Frank Z; Egleston, Brian L et al. (2011) Serum antimullerian hormone in healthy premenopausal women. Fertil Steril 95:2718-21
Rico, Mario C; Rough, James J; Del Carpio-Cano, Fabiola E et al. (2010) The axis of thrombospondin-1, transforming growth factor beta and connective tissue growth factor: an emerging therapeutic target in rheumatoid arthritis. Curr Vasc Pharmacol 8:338-43
Rough, James; Engdahl, Ryan; Opperman, Kay et al. (2009) beta2 Adrenoreceptor blockade attenuates the hyperinflammatory response induced by traumatic injury. Surgery 145:235-42
Engdahl, Ryan; Monroy, M Alexandra; Daly, John M (2007) 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) mediates repression of TNF-alpha by decreasing levels of acetylated histone H3 and H4 at its promoter. Biochem Biophys Res Commun 359:88-93